Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind multicenter trial of nifuratel and nystatin vaginal soft capsules for vulvovaginal candidiasis
CTR20244417Phase 3Active
- Sponsor
- Zhuzhou Qianjin Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuratel + nystatin in vulvovaginal candidiasis (VVC), sponsored by Zhuzhou Qianjin Pharmaceutical Co., Ltd.. Started Dec 2024; status: active.
02
Drugs
nifuratel + nystatin
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on CTR20244417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244417.